
Savitha M. Rao
Examiner (ID: 10492, Phone: (571)270-5315 , Office: P/1621 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1629, 1614, 1621, 1691, 4131 |
| Total Applications | 1525 |
| Issued Applications | 872 |
| Pending Applications | 108 |
| Abandoned Applications | 583 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9227643
[patent_doc_number] => 08633311
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-21
[patent_title] => 'Topical application of porphyrins for killing or preventing the growth of bacteria or fungi on a mammal'
[patent_app_type] => utility
[patent_app_number] => 13/056441
[patent_app_country] => US
[patent_app_date] => 2009-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 5382
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13056441
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/056441 | Topical application of porphyrins for killing or preventing the growth of bacteria or fungi on a mammal | Jul 28, 2009 | Issued |
Array
(
[id] => 10892984
[patent_doc_number] => 08916596
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-23
[patent_title] => 'Preventing or treating viral infection using an inhibitor of the LSD1 protein, a MAO inhibitor or an inhibitor of LSD1 and a MAO inhibitor'
[patent_app_type] => utility
[patent_app_number] => 13/055587
[patent_app_country] => US
[patent_app_date] => 2009-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9538
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13055587
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/055587 | Preventing or treating viral infection using an inhibitor of the LSD1 protein, a MAO inhibitor or an inhibitor of LSD1 and a MAO inhibitor | Jul 22, 2009 | Issued |
Array
(
[id] => 6072458
[patent_doc_number] => 20110138888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'TREATMENT OF OBESITY'
[patent_app_type] => utility
[patent_app_number] => 13/054891
[patent_app_country] => US
[patent_app_date] => 2009-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 20808
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20110138888.pdf
[firstpage_image] =>[orig_patent_app_number] => 13054891
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/054891 | TREATMENT OF OBESITY | Jul 20, 2009 | Abandoned |
Array
(
[id] => 6630271
[patent_doc_number] => 20100004324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-07
[patent_title] => 'ANTIMICROBIAL COMPOUNDS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/491988
[patent_app_country] => US
[patent_app_date] => 2009-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 19275
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20100004324.pdf
[firstpage_image] =>[orig_patent_app_number] => 12491988
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/491988 | Antimicrobial compounds and methods of use thereof | Jun 24, 2009 | Issued |
Array
(
[id] => 6257988
[patent_doc_number] => 20100029765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'TOPICAL AQUEOUS COMPOSITION COMPRISING TRETINOIN'
[patent_app_type] => utility
[patent_app_number] => 12/485731
[patent_app_country] => US
[patent_app_date] => 2009-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3929
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20100029765.pdf
[firstpage_image] =>[orig_patent_app_number] => 12485731
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/485731 | TOPICAL AQUEOUS COMPOSITION COMPRISING TRETINOIN | Jun 15, 2009 | Abandoned |
Array
(
[id] => 5368554
[patent_doc_number] => 20090306113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'PHARMACEUTICAL FORMULATION'
[patent_app_type] => utility
[patent_app_number] => 12/478934
[patent_app_country] => US
[patent_app_date] => 2009-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4810
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20090306113.pdf
[firstpage_image] =>[orig_patent_app_number] => 12478934
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/478934 | Pharmaceutical formulation | Jun 4, 2009 | Issued |
Array
(
[id] => 6214180
[patent_doc_number] => 20110136813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'WNT PROTEIN SIGNALLING INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/994661
[patent_app_country] => US
[patent_app_date] => 2009-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 24102
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20110136813.pdf
[firstpage_image] =>[orig_patent_app_number] => 12994661
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/994661 | Wnt protein signalling inhibitors | May 26, 2009 | Issued |
Array
(
[id] => 6249487
[patent_doc_number] => 20100137431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'USE OF SUBSTANCES THAT ACT AS CASCADE INHIBITORS OF THE RAF/MEK/ERK SIGNAL CASCADE, FOR PRODUCING A MEDICAMENT TO TREAT DNA AND RNA VIRUSES'
[patent_app_type] => utility
[patent_app_number] => 12/470441
[patent_app_country] => US
[patent_app_date] => 2009-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3567
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20100137431.pdf
[firstpage_image] =>[orig_patent_app_number] => 12470441
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/470441 | USE OF SUBSTANCES THAT ACT AS CASCADE INHIBITORS OF THE RAF/MEK/ERK SIGNAL CASCADE, FOR PRODUCING A MEDICAMENT TO TREAT DNA AND RNA VIRUSES | May 20, 2009 | Abandoned |
Array
(
[id] => 6593271
[patent_doc_number] => 20100130614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'ADMINISTRATION OF ADAPALENE FOR MODULATING THE EXPRESSION OF IL-1ra'
[patent_app_type] => utility
[patent_app_number] => 12/468641
[patent_app_country] => US
[patent_app_date] => 2009-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3832
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20100130614.pdf
[firstpage_image] =>[orig_patent_app_number] => 12468641
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/468641 | ADMINISTRATION OF ADAPALENE FOR MODULATING THE EXPRESSION OF IL-1ra | May 18, 2009 | Abandoned |
Array
(
[id] => 5392278
[patent_doc_number] => 20090209591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'Pharmaceutical product for injection'
[patent_app_type] => utility
[patent_app_number] => 12/385987
[patent_app_country] => US
[patent_app_date] => 2009-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4330
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20090209591.pdf
[firstpage_image] =>[orig_patent_app_number] => 12385987
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/385987 | Pharmaceutical product for injection | Apr 26, 2009 | Abandoned |
Array
(
[id] => 6321874
[patent_doc_number] => 20100113570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'PREVENTION AND TREATMENT OF POST-OPERATIVE COGNITIVE DYSFUNCTION'
[patent_app_type] => utility
[patent_app_number] => 12/428597
[patent_app_country] => US
[patent_app_date] => 2009-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 14273
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20100113570.pdf
[firstpage_image] =>[orig_patent_app_number] => 12428597
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/428597 | PREVENTION AND TREATMENT OF POST-OPERATIVE COGNITIVE DYSFUNCTION | Apr 22, 2009 | Abandoned |
Array
(
[id] => 7682200
[patent_doc_number] => 20100022608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'Non-steroidal anti-inflammatory drugs for cough'
[patent_app_type] => utility
[patent_app_number] => 12/386531
[patent_app_country] => US
[patent_app_date] => 2009-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3963
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20100022608.pdf
[firstpage_image] =>[orig_patent_app_number] => 12386531
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/386531 | Non-steroidal anti-inflammatory drugs for cough | Apr 19, 2009 | Abandoned |
Array
(
[id] => 5458691
[patent_doc_number] => 20090258843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'Compositions Containing Antiviral Compounds and Methods of Using the Same'
[patent_app_type] => utility
[patent_app_number] => 12/420261
[patent_app_country] => US
[patent_app_date] => 2009-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25096
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258843.pdf
[firstpage_image] =>[orig_patent_app_number] => 12420261
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/420261 | Compositions Containing Antiviral Compounds and Methods of Using the Same | Apr 7, 2009 | Abandoned |
Array
(
[id] => 5354727
[patent_doc_number] => 20090186071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-23
[patent_title] => 'CLAY-BASED HEMOSTATIC AGENTS AND DEVICES FOR THE DELIVERY THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/417802
[patent_app_country] => US
[patent_app_date] => 2009-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6070
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20090186071.pdf
[firstpage_image] =>[orig_patent_app_number] => 12417802
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/417802 | CLAY-BASED HEMOSTATIC AGENTS AND DEVICES FOR THE DELIVERY THEREOF | Apr 2, 2009 | Abandoned |
Array
(
[id] => 6150023
[patent_doc_number] => 20110021618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'METHODS OF TREATING FIBROTIC DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/934010
[patent_app_country] => US
[patent_app_date] => 2009-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 7945
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20110021618.pdf
[firstpage_image] =>[orig_patent_app_number] => 12934010
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/934010 | METHODS OF TREATING FIBROTIC DISORDERS | Mar 24, 2009 | Abandoned |
Array
(
[id] => 5404520
[patent_doc_number] => 20090239834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'MCC-257 MODULATION OF NEUROGENESIS'
[patent_app_type] => utility
[patent_app_number] => 12/409421
[patent_app_country] => US
[patent_app_date] => 2009-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11599
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20090239834.pdf
[firstpage_image] =>[orig_patent_app_number] => 12409421
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/409421 | MCC-257 MODULATION OF NEUROGENESIS | Mar 22, 2009 | Abandoned |
Array
(
[id] => 9483184
[patent_doc_number] => 08729135
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-20
[patent_title] => 'Glutaraldehyde composition'
[patent_app_type] => utility
[patent_app_number] => 12/381573
[patent_app_country] => US
[patent_app_date] => 2009-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 3719
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12381573
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/381573 | Glutaraldehyde composition | Mar 12, 2009 | Issued |
Array
(
[id] => 5379450
[patent_doc_number] => 20090191289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'ANTIMICROBIAL COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/402451
[patent_app_country] => US
[patent_app_date] => 2009-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8480
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20090191289.pdf
[firstpage_image] =>[orig_patent_app_number] => 12402451
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/402451 | ANTIMICROBIAL COMPOSITIONS | Mar 10, 2009 | Abandoned |
Array
(
[id] => 7488890
[patent_doc_number] => 08029812
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-04
[patent_title] => 'Personal care compositions'
[patent_app_type] => utility
[patent_app_number] => 12/400309
[patent_app_country] => US
[patent_app_date] => 2009-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14096
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/029/08029812.pdf
[firstpage_image] =>[orig_patent_app_number] => 12400309
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/400309 | Personal care compositions | Mar 8, 2009 | Issued |
Array
(
[id] => 6039500
[patent_doc_number] => 20110092549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => 'Treatment of Sepsis with 5-Ethyl-1-Phenyl-2(1H)-Pyridone'
[patent_app_type] => utility
[patent_app_number] => 12/921107
[patent_app_country] => US
[patent_app_date] => 2009-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8099
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20110092549.pdf
[firstpage_image] =>[orig_patent_app_number] => 12921107
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/921107 | Treatment of sepsis with 5-ethyl-1-phenyl-2(1H)-pyridone | Mar 8, 2009 | Issued |